Multicenter trial

Natriuretic peptide

Ablation

Crossover study

Cardiology

QRS complex

Placebo

Alternative medicine

Heart failure

Radiofrequency ablation

Multicenter study

Internal medicine

Clinical endpoint

Medicine

Ejection fraction

Atrial fibrillation

Randomized controlled trial

Pathology

Heart Rhythm

<h3>Background</h3> Atrioventricular nodal ablation (AVNA) combined with biventricular pacing (BVP) improves outcomes in patients with persistent atrial fibrillation (AF), adequate rate control, and reduced left ventricular ejection fraction (LVEF). His-bundle pacing (HBP) delivers physiological ventricular activation and is a promising alternative to BVP. <h3>Objective</h3> The purpose of this trial was to compare HBP with BVP following AVNA. <h3>Methods</h3> In this multicenter, prospective, randomized crossover trial, we recruited patients with persistent AF and reduced LVEF (≤40%). All patients underwent AVNA and received both HBP and BVP. Patients were randomized to either HBP or BVP for 9 months (phase 1), then were switched to the alternative pacing modality for the next 9 months (phase 2). The primary endpoint was change in LVEF. <h3>Results</h3> Fifty patients (age 64.3 ± 10.3 years; ventricular rate 93.1 ± 19.9 bpm; 72% male) were enrolled. Thirty-eight patients completed the 2 phases and were included in the crossover analysis. A significant improvement in LVEF was observed with HBP compared to BVP (phase 1: ΔLVEF<sub>HBP</sub> 21.3% and ΔLVEF<sub>BVP</sub> 16.7%; phase 2: ΔLVEF<sub>HBP</sub> 3.5% and ΔLVEF<sub>BVP</sub> –2.4%; <i>P</i><sub>generalized</sub> <sub>additive</sub> <sub>model</sub> = 0.015). Significant improvements in left ventricular end-diastolic diameter, New York Heart Association functional class, and B-type natriuretic peptide level were observed with both pacing modalities compared with baseline, whereas no significant differences were observed between HBP and BVP. <h3>Conclusion</h3> HBP delivers a modest but significant improvement in LVEF in patients with persistent AF, impaired ventricular function, and narrow QRS duration post-AVNA compared with BVP. Larger long-term trials are required to confirm the additional improvements in function with HBP.

His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study—The ALTERNATIVE-AF trial